Compile Data Set for Download or QSAR
Report error Found 971 of ic50 for UniProtKB: P12821
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50272062((2S,5S)-1-((S)-3-mercapto-2-methylpropanoyl)-5-(3-...)
Affinity DataIC50: 0.0290nMAssay Description:Inhibition of ACEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 0.100nMAssay Description:Inhibitory activity against Angiotensin I converting enzyme (ACE) from human blood serumMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50073120((4S,6S,9aS)-6-((S)-2-Mercapto-3-phenyl-propionylam...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human ACE using Mca-BK2 as substrate preincubated for 10 mins followed by fluorogenic substrate addition and measured after...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human serum ACEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/1/2020
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of angiotensin converting enzyme (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50175518((3R,7S)-7-((R)-2-Mercapto-3-phenyl-propionylamino)...)
Affinity DataIC50: 0.110nMAssay Description:Inhibitory concentration against angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406389
Affinity DataIC50: 0.115nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM21642((2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolid...)
Affinity DataIC50: 0.120nMAssay Description:Inhibition of human recombinant ACE by fluorimetryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406391
Affinity DataIC50: 0.132nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50272061((2S,5S)-1-((S)-3-mercapto-2-methylpropanoyl)-5-(ph...)
Affinity DataIC50: 0.180nMAssay Description:Inhibition of ACEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406942(CHEMBL80665)
Affinity DataIC50: 0.229nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406908(CHEMBL78629)
Affinity DataIC50: 0.251nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406375(CHEMBL35682)
Affinity DataIC50: 0.288nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406380(CHEMBL284734)
Affinity DataIC50: 0.295nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406392
Affinity DataIC50: 0.295nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50084629(1-(3-Benzoylsulfanyl-2-methyl-propionyl)-4-phenyls...)
Affinity DataIC50: 0.400nMAssay Description:Inhibitory activity against angiotensin I converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406394
Affinity DataIC50: 0.490nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50017125(CHEMBL295690 | 1-[6-Amino-2-(1-carboxy-3-phenyl-pr...)
Affinity DataIC50: 0.5nMAssay Description:Compound tested in vitro for inhibition of Angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406369(CHEMBL289022)
Affinity DataIC50: 0.525nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406370(CHEMBL34832)
Affinity DataIC50: 0.525nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121930(6-(1-Carboxy-3-phenyl-propylamino)-5-oxo-octahydro...)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of Angiotensin I converting enzyme (ACE) in Bothrops jararaca venomMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121930(6-(1-Carboxy-3-phenyl-propylamino)-5-oxo-octahydro...)
Affinity DataIC50: 0.603nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406384(CHEMBL34650)
Affinity DataIC50: 0.631nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50520683(CHEMBL4476621)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of human recombinant ACE using Abz-FRK(Dnp)-P-OH as substrate after 30 mins by fluorimetric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406378(CHEMBL431707)
Affinity DataIC50: 0.776nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406942(CHEMBL80665)
Affinity DataIC50: 0.794nMAssay Description:Inhibition of angiotensin I converting enzyme in silicoMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50017122(7-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1...)
Affinity DataIC50: 0.800nMAssay Description:Compound tested in vitro for inhibition of Angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406372(CHEMBL33025)
Affinity DataIC50: 0.871nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406373(CHEMBL284843)
Affinity DataIC50: 0.891nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50272145((2S,5S)-1-((S)-3-Mercapto-2-methyl-propionyl)-5-(3...)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of ACEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50369775(Mavik | RU-44570 | TRANDOLAPRIL)
Affinity DataIC50: 0.930nMAssay Description:Inhibitory activity against angiotensin I converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50084622((4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)pr...)
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against angiotensin I converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50130714(1-(3-Mercapto-propionyl)-6-methyl-piperidine-2-car...)
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against Angiotensin I converting enzyme (ACE) from bovine kidneyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50146428((S)-1-((1R,5S)-5-Benzoylamino-2-methyl-4-oxo-6-phe...)
Affinity DataIC50: 1nMAssay Description:Inhibition of ACEMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406911(CHEMBL310750)
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50073120((4S,6S,9aS)-6-((S)-2-Mercapto-3-phenyl-propionylam...)
Affinity DataIC50: 1nMAssay Description:Inhibition of human fully glycosylated ACE C-terminal domain expressed in CHO cells using Cbz-Phe-His-Leu as substrate preincubated for 15 mins follo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406909(CHEMBL80779)
Affinity DataIC50: 1.10nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50406387
Affinity DataIC50: 1.10nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367254(ENALAPRILAT)
Affinity DataIC50: 1.20nMAssay Description:Inhibitory concentration (isomer A) against Angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367254(ENALAPRILAT)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Angiotensin I converting enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367254(ENALAPRILAT)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Angiotensin I converting enzyme (ACE) in Bothrops jararaca venomMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Angiotensin I converting enzyme (ACE) in Bothrops jararaca venomMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme 2(Human)
TBA

Curated by ChEMBL
LigandPNGBDBM50017129(Vasotec | Vaseretic | (SSS)1-[2-(1-Ethoxycarbonyl-...)
Affinity DataIC50: 1.20nMAssay Description:In vitro inhibition against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2012
Entry Details Article

TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50021129(CHEMBL39538 | 1-[2-(1-Carboxy-3-phenyl-propylamino...)
Affinity DataIC50: 1.20nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 1.20nMAssay Description:Inhibitory activity against angiotensin converting enzyme (ACE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme 2(Human)
TBA

Curated by ChEMBL
LigandPNGBDBM50367254(ENALAPRILAT)
Affinity DataIC50: 1.20nMAssay Description:In vitro inhibition of Angiotensin I converting enzyme in Hog plasmaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2012
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367254(ENALAPRILAT)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of angiotensin-converting enzyme (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetAngiotensin-converting enzyme(Human)
Santen Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50367879(LISINOPRIL)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of angiotensin-converting enzyme (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetAngiotensin-converting enzyme 2(Human)
TBA

Curated by ChEMBL
LigandPNGBDBM50027132(1-[5-Benzoylamino-6-(3,4-dimethoxy-phenyl)-4-oxo-h...)
Affinity DataIC50: 1.40nMAssay Description:Concentration required to inhibit the activity of Angiotensin I converting enzyme by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 971 total ) | Next | Last >>
Jump to: